Become A Featured Company

FSD Pharma Promotes New Leadership & Advances Projects

Ryan Allway

April 1st, 2019

Exclusive, News

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis last year and the upcoming legalization of oils, concentrates and edibles. Investors have many opportunities in the space, but few companies offer both a massive production footprint and strategic investments in new technologies that could revolutionize the industry.

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is best-known for its massive cannabis production facility that’s under construction in a former Kraft Foods plant, but it has also made compelling investments in a number of innovative technologies in the space. After its recent restructuring, investors may want to take a closer look at the stock as new management re-focuses on unlocking long-term shareholder value.

New FV Pharma President

FSD Pharma recently announced the appointment of Sara May, Ph.D., to President of FV Pharma, a wholly-owned operating subsidiary of FSD Pharma. Dr. May brings over a decade of experience designing, implementing and managing large-scale research projects in field, laboratory, and greenhouse settings, making her uniquely suited for the position. She replaces Mr. Thomas Fairfull who will be transitioning out of the company.

“We are excited to elevate Dr. May’s current position to President of FV Pharma. Her significant experience managing cannabis operations has already proven a great addition to the company,” said FSD Pharma Executive Co-Chairman and CEO Dr. Raza Bokhari in a recent press release. “Her robust expertise has been remarkable and will support efficient advancement of the strategic objectives of FV and FSD Pharma.”

The company also announced that Vladimir Klacar, Auxly Cannabis Group’s nominated Director, has resigned from the Board of Directors at the request of the company following the termination of the company’s joint venture with Auxly Cannabis Group. However, the company’s board still contains many leading cannabis industry voices, including David Urban, Gerald Goldberg, CPA, CA, and many others.

Pivotal Moment in History

Dr. Sara May’s promotion to President of FV Pharma comes on the heels of a wider corporate shakeup. In early-February, the company appointed Dr. Raza Bokhari to interim Chief Executive Officer of FSD Pharma and terminated the company’s joint venture with Auxly Cannabis Group Inc. to continue advancing its flagship cultivation facility after experiencing delays from the originally scheduled December 2019 readiness date.

“We have a clear plan moving forward to build a global retail and medicinal cannabis footprint,” said Dr. Bokhari in the press release announcing the prior updates. “We intend to continue our 220,000 phase 1 building expansion and are assessing different opportunities with strategic partners and construction companies including utilizing our cash, securities and other assets on hand to continue progressing forward.”

In addition to advancing its cultivation plans, the company continues to invest in next generation technologies that could pay big dividends. For example, the company made a $1.5 million strategic investment in Pharmastrip Corp., which is developing a medical cannabis-infused oral thin film strip technology, and signed a non-binding letter of intent with Solarvest BioEnergy Inc. to research the use of algae to produce cannabinoids at scale.

Looking Ahead

FSD Pharma Inc.’s (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) recent management shake-up and joint venture termination underscore its determination to deliver shareholder value by advancing its projects and investments. With the appointment of an experienced FV Pharma president and ongoing investments in new technologies, investors may want to take a closer look at the company over the coming months.

For more information, visit the company’s website at www.fsdpharma.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading